Dr. Nicole Schneiderhan-Marra
Dr. Nicole Schneiderhan-Marra
Head of Pharma & Biotech
- 2020 - today
- Head of Pharma & Biotech
- 2019 - 2020
- Deputy Head of Pharma & Biotech
- 2018 - today
- Head of Department Immunoassays
- 2007 - 2017
- Deputy Head of Department Biochemistry
- 2005 - today
- Project and laboratory manager
- 2003 - 2005
- Scientific employee at the University of Ulm, University Women's Hospital, Endocrinology and Oncology Laboratory, working group Prof. Helmut Deißler and at NMI, working group Biochemistry Thomas Joos
- 2003 - 2003
- Postdoc an der Medizinischen Klinik IV, Nephrologische Forschungslaboratorien, Friedrich-Alexander-Universität Erlangen-Nürnberg, Arbeitsgruppe Goppelt-Strübe.
- 2001 - 2001
- Fellowship of the Boehringer Ingelheim Funds for a research stay at the "MD Anderson Cancer Center", Houston, Texas, USA
Dr. Nicole Schneiderhan-Marra studied biochemistry at the Eberhard Karls University in Tübingen. Her subsequent doctoral thesis was. She also received her doctorate in Tübingen. The practical work of the external doctoral thesis to the Dr. rer. nat. took place in the Medical Clinic IV, Nephrological Research Laboratories, and at the Friedrich-Alexander-University Erlangen-Nuremberg Dr. Schneiderhan-Marra's main focus is on the development, validation and application of antigen arrays and multiplex serological immunoassays for pathogen infection diagnostics. Another focus is the development, validation and application of miniaturized multiplex sandwich immunoassays in proteomics for pharmaceutical and clinical applications. A special focus is also on developments in the field of personalized medicine. Dr. Schneiderhan-Marra has been at the NMI since 2005 and is currently head of the Pharma and Biotech Division.
Selected publications
- Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
Junker D, Becker M, Wagner TR, Kaiser PD, Maier S, Grimm TM, Griesbaum J, Marsall P, Gruber J, Traenkle B, Heinzel C, Pinilla YT, Held J, Fendel R, Kreidenweiss A, Nelde A, Maringer Y, Schroeder S, Walz JS, Althaus K, Uzun G, Mikus M, Bakchoul T, Schenke-Layland K, Bunk S, Haeberle H, Göpel S, Bitzer M, Renk H, Remppis J, Engel C, Franz AR, Harries M, Kessel B, Lange B, Strengert M, Krause G, Zeck A, Rothbauer U, Dulovic A, Schneiderhan-Marra N., Clinical Infectious Disease. 2023; 76(3):e240-e249.
DOI: 10.1093/cid/ciac498.
- Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity.
Becker M., Strengert M., Junker D., Kerrinnes T., Kaiser P.D., Traenkle B., Dinter H., Häring J., Zeck A., Weise F., Peter A., Hörber S., Fink S., Ruoff F., Bakchoul T., Baillot A., Lohse S., Cornberg M., Illig T., Gottlieb J., Smola S., Karch A., Berger K., Rammensee H.-G., Schenke-Layland K., Nelde A., Märklin M., Heitmann J.S., Walz J.S., Templin M., Joos T.O., Rothbauer U., Krause G., Schneiderhan-Marra N., Nature Communications 2021; 12(1):1152.
DOI: 10.1038/s41467-021-20973-3
- Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system.
Calarco S, Fernandez-Carballo BL, Keller T, Weber S, Jakobi M, Marsall P, Schneiderhan-Marra N, Dittrich S., PLoS One. 2023 Jan 20;18(1):e0267516.
DOI: 10.1371/journal.pone.0267516. eCollection 2023.
- Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies.
Häring J, Hassenstein MJ, Becker M, Ortmann J, Junker D, Karch A, Berger K, Tchitchagua T, Leschnik O, Harries M, Gornyk D, Hernández P, Lange B, Castell S, Krause G, Dulovic A, Strengert M, Schneiderhan-Marra N., BMC Infect Dis. 2022 Nov 17;22(1):859.
DOI: 10.1186/s12879-022-07863-9.
- CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers.
Lerche S, Zimmermann M, Wurster I, Roeben B, Fries FL, Deuschle C, Waniek K, Lachmann I, Gasser T, Jakobi M, Joos TO, Schneiderhan-Marra N, Brockmann K., Front Neurol. 2022;13:834580.
DOI: 10.3389/fneur.2022.834580. eCollection 2022.
- Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based Multiplex Serological Assay.
Filomena A, Göpfert JC, Duffy D, Pol S, Abdel-Hamid M, Esmat G, Fontanet A, Albert ML, Joos TO, Schneiderhan-Marra N., High Throughput. 2017;6(4):15.
DOI: 10.3390/ht6040015.
ORCID: 0000-0001-6785-181X
Link to Publications: schneiderhan-marra n or schneiderhan n - Search Results - PubMed (nih.gov)
Selected Projects
NMI Natural and Medical Sciences Institute
at the University of Tübingen
Markwiesenstraße 55, 72770 Reutlingen
Tel.: +49 7121 51530-0
Mail: info@nmi.de
Follow us now
